98 related articles for article (PubMed ID: 11297766)
1. Genetic heterogeneity and alterations in chromosome 9 loci in a localized region of a functional pituitary adenoma.
Jotwani G; Misra A; Chattopadhyay P; Sarkar C; Mahapatra AK; Sinha S
Cancer Genet Cytogenet; 2001 Feb; 125(1):41-5. PubMed ID: 11297766
[TBL] [Abstract][Full Text] [Related]
2. Chromosome 9p deletions in invasive and noninvasive nonfunctional pituitary adenomas: the deleted region involves markers outside of the MTS1 and MTS2 genes.
Farrell WE; Simpson DJ; Bicknell JE; Talbot AJ; Bates AS; Clayton RN
Cancer Res; 1997 Jul; 57(13):2703-9. PubMed ID: 9205080
[TBL] [Abstract][Full Text] [Related]
3. Frequent loss of the CDKN2C (p18INK4c) gene product in pituitary adenomas.
Kirsch M; Mörz M; Pinzer T; Schackert HK; Schackert G
Genes Chromosomes Cancer; 2009 Feb; 48(2):143-54. PubMed ID: 18973139
[TBL] [Abstract][Full Text] [Related]
4. Extensive intra-tumor heterogeneity in primary human glial tumors as a result of locus non-specific genomic alterations.
Misra A; Chattopadhyay P; Dinda AK; Sarkar C; Mahapatra AK; Hasnain SE; Sinha S
J Neurooncol; 2000 May; 48(1):1-12. PubMed ID: 11026691
[TBL] [Abstract][Full Text] [Related]
5. The p15(INK4b)/p16(INK4a)/RB1 pathway is frequently deregulated in human pituitary adenomas.
Ogino A; Yoshino A; Katayama Y; Watanabe T; Ota T; Komine C; Yokoyama T; Fukushima T
J Neuropathol Exp Neurol; 2005 May; 64(5):398-403. PubMed ID: 15892297
[TBL] [Abstract][Full Text] [Related]
6. p16 (INK4a, MTS-1) gene polymorphism and methylation status in human pituitary tumours.
Jaffrain-Rea ML; Ferretti E; Toniato E; Cannita K; Santoro A; Di Stefano D; Ricevuto E; Maroder M; Tamburrano G; Cantore G; Gulino A; Martinotti S
Clin Endocrinol (Oxf); 1999 Sep; 51(3):317-25. PubMed ID: 10469011
[TBL] [Abstract][Full Text] [Related]
7. Hypermethylation of the p16/CDKN2A/MTSI gene and loss of protein expression is associated with nonfunctional pituitary adenomas but not somatotrophinomas.
Simpson DJ; Bicknell JE; McNicol AM; Clayton RN; Farrell WE
Genes Chromosomes Cancer; 1999 Apr; 24(4):328-36. PubMed ID: 10092131
[TBL] [Abstract][Full Text] [Related]
8. Structure of the thyrotrophin-releasing hormone receptor in human pituitary adenomas.
Faccenda E; Melmed S; Bevan JS; Eidne KA
Clin Endocrinol (Oxf); 1996 Mar; 44(3):341-7. PubMed ID: 8729534
[TBL] [Abstract][Full Text] [Related]
9. Loss of heterozygosity on the short arm of chromosome 9 without p16 gene mutation in gastric carcinomas.
Sakata K; Tamura G; Maesawa C; Suzuki Y; Terashima M; Satoh K; Eda Y; Suzuki A; Sekiyama S; Satodate R
Jpn J Cancer Res; 1995 Apr; 86(4):333-5. PubMed ID: 7775254
[TBL] [Abstract][Full Text] [Related]
10. Molecular screening of pituitary adenomas for gene mutations and rearrangements.
Herman V; Drazin NZ; Gonsky R; Melmed S
J Clin Endocrinol Metab; 1993 Jul; 77(1):50-5. PubMed ID: 8100831
[TBL] [Abstract][Full Text] [Related]
11. p53 gene mutations in pituitary adenomas: rare events.
Levy A; Hall L; Yeudall WA; Lightman SL
Clin Endocrinol (Oxf); 1994 Dec; 41(6):809-14. PubMed ID: 7889618
[TBL] [Abstract][Full Text] [Related]
12. Infrequent mutations of p27Kip1 gene and trisomy 12 in a subset of human pituitary adenomas.
Tanaka C; Yoshimoto K; Yang P; Kimura T; Yamada S; Moritani M; Sano T; Itakura M
J Clin Endocrinol Metab; 1997 Sep; 82(9):3141-7. PubMed ID: 9284759
[TBL] [Abstract][Full Text] [Related]
13. Aberrant expression of G(1)/S regulators is a frequent event in sporadic pituitary adenomas.
Simpson DJ; Frost SJ; Bicknell JE; Broome JC; McNicol AM; Clayton RN; Farrell WE
Carcinogenesis; 2001 Aug; 22(8):1149-54. PubMed ID: 11470742
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide amplification and allelotyping of sporadic pituitary adenomas identify novel regions of genetic loss.
Simpson DJ; Bicknell EJ; Buch HN; Cutty SJ; Clayton RN; Farrell WE
Genes Chromosomes Cancer; 2003 Jul; 37(3):225-36. PubMed ID: 12759921
[TBL] [Abstract][Full Text] [Related]
15. Detection of somatic DNA alterations in azoxymethane-induced F344 rat colon tumors by random amplified polymorphic DNA analysis.
Luceri C; De Filippo C; Caderni G; Gambacciani L; Salvadori M; Giannini A; Dolara P
Carcinogenesis; 2000 Sep; 21(9):1753-6. PubMed ID: 10964108
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of molecular genetic changes in sporadic invasive pituitary adenomas.
Nam DH; Song SY; Park K; Kim MH; Suh YL; Lee JI; Kim JS; Hong SC; Shin HJ; Park K; Eoh W; Kim JH
Exp Mol Med; 2001 Sep; 33(3):111-6. PubMed ID: 11642545
[TBL] [Abstract][Full Text] [Related]
17. Loss of chromosome arm 9p DNA and analysis of the p16 and p15 cyclin-dependent kinase inhibitor genes in human parathyroid adenomas.
Tahara H; Smith AP; Gaz RD; Arnold A
J Clin Endocrinol Metab; 1996 Oct; 81(10):3663-7. PubMed ID: 8855819
[TBL] [Abstract][Full Text] [Related]
18. Alterations of the INK4a-ARF gene locus in pleomorphic adenoma of the parotid gland.
Weber A; Langhanki L; Schütz A; Wittekind C; Bootz F; Tannapfel A
J Pathol; 2002 Nov; 198(3):326-34. PubMed ID: 12375265
[TBL] [Abstract][Full Text] [Related]
19. Familial isolated pituitary adenoma: evidence for genetic heterogeneity.
Toledo RA; Lourenço DM; Toledo SPA
Front Horm Res; 2010; 38():77-86. PubMed ID: 20616498
[TBL] [Abstract][Full Text] [Related]
20. Genomic sequence analysis of a key residue (Arg183) in human G alpha q in invasive non-functional pituitary adenomas.
Farrell WE; Talbot JA; Bicknell EJ; Simpson D; Clayton RN
Clin Endocrinol (Oxf); 1997 Aug; 47(2):241-4. PubMed ID: 9302401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
